Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Presbyopia-correcting eye drop receives FDA approval
➤ Four-year, first-in-human results for IOL-based drug delivery system
➤ FDA approves new treatment for thyroid eye disease
➤ New registry establishes baseline for interventional glaucoma procedures in the U.S.
➤ Phase 3 study for DME does not meet primary endpoint, triggering strategic decisions
➤ Company news
➤ ASCRS news and events
➤ EyeWorld article of the week
➤ Phase 4 results for iDose TR
➤ Phase 3 extension study showcases positive results with epithelium-on crosslinking
➤ 6-month results from bio-reinforced canaloplasty procedure for glaucoma
➤ Dosing update in Phase 1 study evaluating mRNA treatment of optic atrophy
➤ Enrollment complete in Phase 2a study for geographic atrophy
➤ IND amendment submitted to FDA to expand indication for product candidate
➤ Complimentary access to video journal
➤ Company news
➤ ASCRS news and events
➤ EyeWorld article of the week
The contributing physicians in the Glaucoma section “highlight how long-standing techniques are being modernized with contemporary data and how emerging modalities are finding their precise place within a multimodal toolkit,” said Manjool Shah, MD, as he previewed what readers will find here.
Finding the most effective way to approach a patient with glaucoma can be a challenge, and it may take time to find the best treatment or combination of treatments. Three physicians discussed how they are combining medications with procedural intervention and the future of treatments in the glaucoma field.
In Dr. Provencher’s cyclopexy technique, a long-curved CTC needle with 10-0 Prolene is passed directly through sclera to reappose the ciliary body in the area of the cleft (demarcated by violet marking pen).
Source: Lorraine Provencher, MD
In a fast-paced session at the 2026 ASCRS Annual Meeting, presenters shared videos and pearls on a variety of glaucoma topics, competing for audience votes in this Survivor-themed symposium. Audience members voted off one speaker per round until there was one remaining survivor on “Temporal Island.” Read the recap here.
➤ IDE approval for initiation of feasibility study for glaucoma uveal spacer
➤ Launch of premium ophthalmic microscope
➤ Acceptance of BLA for treatment of retinitis pigmentosa with severe vision loss
➤ Launch of new feature for virtual reality patient education platform
➤ Launch of new pretest for VR-powered diagnostic headset
➤ Company news
➤ ASCRS news and events
➤ EyeWorld article of the week
“In this quarter's issue, we dive into the overarching theme of expanding digital technologies, while also continuing our exploration of nuanced clinical challenges that require our steadfast, long-term vigilance,” said Glaucoma Editor Manjool Shah, MD, introducing the articles in the section on digital tools in glaucoma care and traumatic glaucoma.
In the past, EyeWorld has delved into nuanced glaucoma subtypes. Here, two physicians discussed traumatic glaucoma, including when it occurs, diagnostic tools, and management options.
➤ First patient dosed in Phase 3 trial for treatment of X-linked retinoschisis
➤ New treatment option for glaucoma
➤ BLA resubmission received by FDA for wet AMD treatment
➤ Company news
➤ Grant opportunity
➤ ASCRS news and events
➤ EyeWorld article of the week
When it comes to development and utilization of big data and AI for diagnostic and patient care decisions, there is a lot of work being done in this area to advance glaucoma care to being more proactive rather than reactive. Read what two ophthalmologists had to say on this topic.
